Kyle Bass Challenges Biogen Fumaderm Patent

By: via Benzinga
A patent held by Biogen Inc (NASDAQ: BIIB) on its Fumaderm psoriasis treatment got challenged Tuesday by hedge fund manager and short ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.